When malignant tumors appear in the body, the ratio of CD4+/CD8+ also decreases significantly, and lung cancer patients are in a state of immunosuppression [12], which makes lung cancer patients susceptible to COVID-19. This evidence concerns the gene CD8A and COVID-19.